Alembic Pharmaceuticals
APLLTD.NS
#3990
Rank
A$3.60 B
Marketcap
$18.35
Share price
-1.68%
Change (1 day)
33.85%
Change (1 year)

Earnings for Alembic Pharmaceuticals (APLLTD.NS)

Earnings in 2024 (TTM): A$0.12 Billion

According to Alembic Pharmaceuticals's latest financial reports the company's current earnings are A$0.74 Billion. In 2023 the company made an earning of A$0.11 Billion, an increase over its 2022 earnings that were of A$59.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alembic Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.12 B13.04%
2023 A$0.11 B92%
2022 A$59.66 M-67.23%
2021 A$0.18 B-34.41%
2020 A$0.27 B42.15%
2019 A$0.19 B18.17%
2018 A$0.16 B36.49%
2017 A$0.12 B-1.16%
2016 A$0.12 B-41.83%
2015 A$0.21 B139.55%
2014 A$87.9 M14.1%
2013 A$77.03 M